{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:56:00Z","timestamp":1791064560404,"version":"4.1.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1093\/rheumatology\/ker282","type":"journal-article","created":{"date-parts":[[2011,10,10]],"date-time":"2011-10-10T10:09:02Z","timestamp":1318241342000},"page":"2197-2205","source":"Crossref","is-referenced-by-count":52,"title":["Increased levels of BAFF in patients with systemic lupus erythematosus are associated with acute-phase reactants, independent of BAFF genetics: a case\u2013control study"],"prefix":"10.1093","volume":"50","author":[{"given":"Gro \u00d8.","family":"Eilertsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijke","family":"Van Ghelue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Strand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes C.","family":"Nossent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,10,8]]},"reference":[{"key":"key\n\t\t\t\t20170522114259_ker282-B1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/978-0-387-89520-8_4","article-title":"Targeting of BAFF and APRIL for autoimmunity and oncology","volume":"647","author":"Ryan","year":"2009","journal-title":"Adv Exp Med Biol"},{"key":"key\n\t\t\t\t20170522114259_ker282-B2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.coi.2007.04.008","article-title":"B cells and the BAFF\/APRIL axis: fast-forward on autoimmunity and signaling","volume":"19","author":"Mackay","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"key\n\t\t\t\t20170522114259_ker282-B3","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.4049\/jimmunol.181.3.2211","article-title":"Excessive production of IFN-gamma in patients with systemic lupus erythematosus and its contribution to induction of B lymphocyte stimulator\/B cell-activating factor\/TNF ligand superfamily-13B","volume":"181","author":"Harigai","year":"2008","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20170522114259_ker282-B4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cyto.2008.06.005","article-title":"Effect of interleukin-2 on synthesis of B cell activating factor belonging to the tumor necrosis factor family (BAFF) in human peripheral blood mononuclear cells","volume":"44","author":"Suzuki","year":"2008","journal-title":"Cytokine"},{"key":"key\n\t\t\t\t20170522114259_ker282-B5","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nri2572","article-title":"Cracking the BAFF code","volume":"9","author":"Mackay","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"key\n\t\t\t\t20170522114259_ker282-B6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1172\/JCI0214121","article-title":"Association of BAFF\/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome","volume":"109","author":"Groom","year":"2002","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170522114259_ker282-B7","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1073\/pnas.97.7.3370","article-title":"Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice","volume":"97","author":"Khare","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170522114259_ker282-B8","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1084\/jem.190.11.1697","article-title":"Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations","volume":"190","author":"Mackay","year":"1999","journal-title":"J Exp Med"},{"key":"key\n\t\t\t\t20170522114259_ker282-B9","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/art.27368","article-title":"Selective blockade of BAFF for the prevention and treatment of systemic lupus erythematosus nephritis in NZM2410 mice","volume":"62","author":"Ramanujam","year":"2010","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522114259_ker282-B10","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1177\/0961203306071871","article-title":"B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time","volume":"15","author":"Becker-Merok","year":"2006","journal-title":"Lupus"},{"key":"key\n\t\t\t\t20170522114259_ker282-B11","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1002\/art.23678","article-title":"Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus","volume":"58","author":"Petri","year":"2008","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522114259_ker282-B12","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1002\/art.11354","article-title":"B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations","volume":"48","author":"Stohl","year":"2003","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522114259_ker282-B13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4049\/jimmunol.166.1.6","article-title":"Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus","volume":"166","author":"Zhang","year":"2001","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20170522114259_ker282-B14","first-page":"176","article-title":"The genetic contribution to systemic lupus erythematosus","volume":"66","author":"Criswell","year":"2008","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"key\n\t\t\t\t20170522114259_ker282-B15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/gene.2009.39","article-title":"Recent insights into the genetic basis of systemic lupus erythematosus","volume":"10","author":"Moser","year":"2009","journal-title":"Genes Immun"},{"key":"key\n\t\t\t\t20170522114259_ker282-B16","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nrrheum.2010.68","article-title":"B cells as therapeutic targets in SLE","volume":"6","author":"Sanz","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"key\n\t\t\t\t20170522114259_ker282-B17","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/sj.gene.6363923","article-title":"Analysis on the association of human BLYS (BAFF, TNFSF13B) polymorphisms with systemic lupus erythematosus and rheumatoid arthritis","volume":"3","author":"Kawasaki","year":"2002","journal-title":"Genes Immun"},{"key":"key\n\t\t\t\t20170522114259_ker282-B18","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/rheumatology\/ken246","article-title":"Polymorphism in the 5\u2032 regulatory region of the B-lymphocyte activating factor gene is associated with the Ro\/La autoantibody response and serum BAFF levels in primary Sjogren's syndrome","volume":"47","author":"Nossent","year":"2008","journal-title":"Rheumatology"},{"key":"key\n\t\t\t\t20170522114259_ker282-B19","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar1884","article-title":"No evidence for an association between the -871 T\/C promoter polymorphism in the B-cell-activating factor gene and primary Sjogren's syndrome","volume":"8","author":"Gottenberg","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"key\n\t\t\t\t20170522114259_ker282-B20","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.clinbiochem.2006.09.010","article-title":"Correlation of the expression levels of BLyS and its receptors mRNA in patients with systemic lupus erythematosus","volume":"39","author":"Ju","year":"2006","journal-title":"Clin Biochem"},{"key":"key\n\t\t\t\t20170522114259_ker282-B21","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American Collage of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522114259_ker282-B22","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522114259_ker282-B23","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","article-title":"Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE","volume":"35","author":"Bombardier","year":"1992","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522114259_ker282-B24","first-page":"820","article-title":"A comparison of prospective and retrospective evaluations of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology Damage Index for systemic lupus erythematosus","volume":"32","author":"Bernatsky","year":"2005","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170522114259_ker282-B25","first-page":"53","article-title":"Validity and reliability of lupus activity measures in the routine clinic setting","volume":"19","author":"Petri","year":"1992","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170522114259_ker282-B26","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/bioinformatics\/btl268","article-title":"SNPStats: a web tool for the analysis of association studies","volume":"22","author":"Sole","year":"2006","journal-title":"Bioinformatics"},{"key":"key\n\t\t\t\t20170522114259_ker282-B27","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s10875-006-9026-2","article-title":"Mutational analysis of human BLyS in patients with common variable immunodeficiency","volume":"26","author":"Losi","year":"2006","journal-title":"J Clin Immunol"},{"key":"key\n\t\t\t\t20170522114259_ker282-B28","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrrheum.2010.176","article-title":"Genetic susceptibility to systemic lupus erythematosus in the genomic era","volume":"6","author":"Deng","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"key\n\t\t\t\t20170522114259_ker282-B29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/BOR.0b013e3283361943","article-title":"Genetics research in systemic lupus erythematosus for clinicians: methodology, progress, and controversies","volume":"22","author":"Kaiser","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"key\n\t\t\t\t20170522114259_ker282-B30","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nrrheum.2010.63","article-title":"Genetics of SLE: evidence from mouse models","volume":"6","author":"Morel","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"key\n\t\t\t\t20170522114259_ker282-B31","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.4049\/jimmunol.177.4.2671","article-title":"Paucity of clinical disease despite serological autoimmunity and kidney pathology in lupus-prone New Zealand mixed 2328 mice deficient in BAFF","volume":"177","author":"Jacob","year":"2006","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20170522114259_ker282-B32","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-3083.2005.01688.x","article-title":"The BAFF\/APRIL system in systemic autoimmune diseases with a special emphasis on Sjogren's syndrome","volume":"62","author":"Szodoray","year":"2005","journal-title":"Scand J Immunol"},{"key":"key\n\t\t\t\t20170522114259_ker282-B33","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170522114259_ker282-B34","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/ar2964","article-title":"Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus","volume":"12","author":"Shah","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"key\n\t\t\t\t20170522114259_ker282-B35","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/rheumatology\/kem097","article-title":"Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production","volume":"46","author":"Morimoto","year":"2007","journal-title":"Rheumatology"},{"key":"key\n\t\t\t\t20170522114259_ker282-B36","doi-asserted-by":"crossref","first-page":"793","DOI":"10.4049\/jimmunol.182.2.793","article-title":"Increased CD4+Foxp3+ T cells in BAFF-transgenic mice suppress T cell effector responses","volume":"182","author":"Walters","year":"2009","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20170522114259_ker282-B37","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S","article-title":"Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases","volume":"44","author":"Cheema","year":"2001","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522114259_ker282-B38","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1172\/JCI25265","article-title":"BLyS and APRIL in rheumatoid arthritis","volume":"115","author":"Seyler","year":"2005","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170522114259_ker282-B39","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1186\/ar1912","article-title":"B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjogren's syndrome","volume":"8","author":"Ittah","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"key\n\t\t\t\t20170522114259_ker282-B40","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.4049\/jimmunol.180.3.1938","article-title":"Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis","volume":"180","author":"Schiffer","year":"2008","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20170522114259_ker282-B41","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1600-065X.2008.00625.x","article-title":"BAFF blockade for systemic lupus erythematosus: will the promise be fulfilled?","volume":"223","author":"Ramanujam","year":"2008","journal-title":"Immunol Rev"},{"key":"key\n\t\t\t\t20170522114259_ker282-B42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2249.2009.04007.x","article-title":"BAFF: a local and systemic target in autoimmune diseases","volume":"158","author":"Moisini","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"key\n\t\t\t\t20170522114259_ker282-B43","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nrrheum.2010.64","article-title":"Cytokines as therapeutic targets in SLE","volume":"6","author":"Ronnblom","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"key\n\t\t\t\t20170522114259_ker282-B44","first-page":"633","article-title":"Cytokine panel and histopathological aspects in the systemic lupus erythematosus","volume":"51","author":"Avramescu","year":"2010","journal-title":"Rom J Morphol Embryol"},{"key":"key\n\t\t\t\t20170522114259_ker282-B45","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cyto.2006.07.023","article-title":"Proinflammatory cytokines (TNF-alpha and IL-6) in Egyptian patients with SLE: its correlation with disease activity","volume":"35","author":"Sabry","year":"2006","journal-title":"Cytokine"},{"key":"key\n\t\t\t\t20170522114259_ker282-B46","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/0961203310392432","article-title":"Interleukin-6 promotes arthritis and joint deformation in patients with systemic lupus erythematosus","volume":"20","author":"Eilertsen","year":"2011","journal-title":"Lupus"},{"key":"key\n\t\t\t\t20170522114259_ker282-B47","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/art.27502","article-title":"Constitutive overexpression of BAFF in autoimmune-resistant mice drives only some aspects of systemic lupus erythematosus-like autoimmunity","volume":"62","author":"Stohl","year":"2010","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522114259_ker282-B48","doi-asserted-by":"crossref","first-page":"J258","DOI":"10.1016\/j.jaut.2009.12.003","article-title":"Effects of tobacco smoke on immunity, inflammation and autoimmunity","volume":"34","author":"Arnson","year":"2010","journal-title":"J Autoimmun"},{"key":"key\n\t\t\t\t20170522114259_ker282-B49","doi-asserted-by":"crossref","first-page":"7164","DOI":"10.4049\/jimmunol.177.10.7164","article-title":"Airway epithelial cells produce B cell-activating factor of TNF family by an IFN-beta-dependent mechanism","volume":"177","author":"Kato","year":"2006","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20170522114259_ker282-B50","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/BOR.0b013e3283374e78","article-title":"Re-evaluation of biologic therapies in systemic lupus erythematosus","volume":"22","author":"Bruce","year":"2010","journal-title":"Curr Opin Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/50\/12\/2197\/17387229\/ker282.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T00:07:54Z","timestamp":1503533274000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-lookup\/doi\/10.1093\/rheumatology\/ker282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,8]]},"references-count":50,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2011,10,8]]},"published-print":{"date-parts":[[2011,12]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/ker282","relation":{},"ISSN":["1462-0332","1462-0324"],"issn-type":[{"value":"1462-0332","type":"electronic"},{"value":"1462-0324","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10,8]]}}}